Open AccessLYAR promotes the proliferation of non-small cell lung cancer and is associated with poor prognosis
Author(s) -
Xin Lu,
Guanjun Ju,
Yuxin Wang,
Yongliang Wang,
Kun Wang,
Jianle Chen,
Wei Cai,
Qi-Wei Zang
Publication year - 2021
Publication title -
folia histochemica et cytobiologica
Language(s) - English
Resource type - Journals
eISSN - 1897-5631
pISSN - 0239-8508
DOI - 10.5603/fhc.a2021.0030
Subject(s) - cell cycle , cell growth , cancer research , apoptosis , proliferating cell nuclear antigen , flow cytometry , tunel assay , terminal deoxynucleotidyl transferase , immunohistochemistry , lung cancer , biology , cyclin d1 , gene knockdown , pathology , medicine , microbiology and biotechnology , immunology , biochemistry , genetics
The aim of the study was to investigate the clinical significance of Ly-1 antibody reactive clone (LYAR) in non-small-cell lung cancer (NSCLC).